RXST Stock Analysis: Buy, Sell, or Hold?
RXST - RxSight, Inc. Common Stock
$6.16
0.07 (1.15%)
▲
5d:
-1.6%
30d:
-19.05%
90d:
-42.7%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
RXST is down 6.8% this week, but smart money is accumulating calls. Top strike: $7.5 2026-04-17 with 1 OI. Call ratio: 100% View Scanner →
Strength: 8.4/10
Get Alerted When RXST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RXST shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: RXST shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: RXST is currently trading at $6.16, which is considered oversold relative to its 30-day fair value range of $6.56 to $8.19.
Technical Outlook: Technically, RXST is in a strong downtrend. Immediate support is located at $5.90, while resistance sits at $7.53.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.21 (+65.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RXST is in a strong downtrend. Immediate support is located at $5.90, while resistance sits at $7.53.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.21 (+65.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.56 -
$8.19
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 65.8% below Wall St target ($10.21)
Fair Price Analysis
30-Day Fair Range
$6.56 -
$8.19
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$5.90
Resistance Level
$7.53
Current Trend
Strong Downtrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.77
Wall Street Target
$10.21
(+65.8%)
Revenue Growth (YoY)
-18.9%
Profit Margin
-29.0%
Share & Embed Analysis
Last updated: March 31, 2026 8:16 PM ET
Data refreshes hourly during market hours. Next update: 9:16 PM
Data refreshes hourly during market hours. Next update: 9:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RXST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 53 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 52 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 53 HOLD |
